These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15838359)

  • 1. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure.
    Abassi Z; Francis B; Wessale J; Ovcharenko E; Winaver J; Hoffman A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():245S-248S. PubMed ID: 12193096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
    Lee TM; Chen CC; Lin MS; Chang NC
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
    Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
    Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure.
    Francis BN; Abassi Z; Heyman S; Winaver J; Hoffman A
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S362-5. PubMed ID: 15838321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure.
    Brodsky S; Gurbanov K; Abassi Z; Hoffman A; Ruffolo RR; Feuerstein GZ; Winaver J
    Hypertension; 1998 Oct; 32(4):746-52. PubMed ID: 9774374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans.
    Honing MLH; Hijmering ML; Ballard DE; Yang YP; Padley RJ; Morrison PJ; Rabelink TJ
    J Am Soc Nephrol; 2000 Aug; 11(8):1498-1504. PubMed ID: 10906163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
    Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
    Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.
    Sachidanandam K; Elgebaly MM; Harris AK; Hutchinson JR; Mezzetti EM; Portik-Dobos V; Ergul A
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2743-9. PubMed ID: 18424628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
    Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats.
    Nakano D; Pollock DM
    Hypertension; 2009 Feb; 53(2):324-30. PubMed ID: 19104001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic activation of endothelin B receptors: new model of experimental hypertension.
    Fink G; Li M; Lau Y; Osborn J; Watts S
    Hypertension; 2007 Sep; 50(3):512-8. PubMed ID: 17664390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
    Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
    Ding SS; Qiu C; Hess P; Xi JF; Clozel JP; Clozel M
    Cardiovasc Res; 2002 Mar; 53(4):963-70. PubMed ID: 11922906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
    Vernerová Z; Kujal P; Kramer HJ; Bäcker A; Cervenka L; Vaneckova I
    Physiol Res; 2009; 58 Suppl 2():S69-S78. PubMed ID: 20131938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.
    Feng HQ; Weymouth ND; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G27-33. PubMed ID: 19299580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.
    Intapad S; Ojeda NB; Varney E; Royals TP; Alexander BT
    Hypertension; 2015 Dec; 66(6):1260-6. PubMed ID: 26459423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.
    Saleh MA; Pollock JS; Pollock DM
    J Pharmacol Exp Ther; 2011 Jul; 338(1):263-70. PubMed ID: 21471190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.